Thani Jambulingam, PhD

home / authors / thani-jambulingam-phd

Articles

Credit: zimmytws | stock.adobe.com. Balancing profitability with affordability, redesigning supply chains for resilience, and engaging actively in trade policy discussions are no longer optional, they are strategic imperatives.

How Can Pharma Leadership Prepare for the Current Tariff Environment and Potential Changes in 2026?

August 1st 2025

The 15% tariff on pharmaceutical imports from the European Union is not a short term inconvenience, it represents a structural shift in the economics of the US pharmaceutical market.

Credit: AspctStyle | stock.adobe.com. Group of pharmacists standing together and looking at the camera in a chemist. Group of healthcare professionals working in a pharmacy.

Flawless but Fake? The Ethics of AI Social Media Influencers in Pharmaceutical Advertising

Thani Jambulingam, PhD

July 29th 2025

AI influencers represent the cutting edge of digital storytelling. But when applied to pharmaceutical marketing, innovation must be balanced with integrity.

Credit: rudall30 | stock.adobe.com. Hands offering money with a circular chart at the center, symbolizing shareholder equity, crowdfunding, business partnerships, and investments

Capital Allocation is Strategy: Five Imperatives for Biopharma Leaders

Thani Jambulingam, PhD

July 16th 2025

Executives who treat capital allocation as a CEO-level strategic discipline are best positioned to thrive in a volatile and increasingly capital-constrained environment.

Credit: xyz+ | stock.adobe.com. Bridging Vision and Value: How Target Product Profiles and Value Evidence Archetypes Must Align for Market Access Success

Bridging Vision and Value: How Target Product Profiles and Value Evidence Archetypes Must Align for Market Access Success

Thani Jambulingam, PhD

June 3rd 2025

In today’s environment, aligning the Target Product Profile with the appropriate Value Evidence Archetype is not just good practice, it is a strategic imperative.